Chapter 1.  GASTROINTESTINAL THERAPEUTICS MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.  GASTROINTESTINAL THERAPEUTICS MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3.  GASTROINTESTINAL THERAPEUTICS MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.  GASTROINTESTINAL THERAPEUTICS MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5.  GASTROINTESTINAL THERAPEUTICS MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. GASTROINTESTINAL THERAPEUTICS MARKET – By Type

6.1. Generics

6.2. Branded

Chapter 7.  GASTROINTESTINAL THERAPEUTICS MARKET – By Drug Class

7.1. Anti-Emetics

7.2. H2 Antagonists

7.3. Anti-Diarrheal

7.4. Biologics/Biosimilar

7.5. Aminosalicylates

7.6. Digestive enzymes

7.7. Proton Pump Inhibitors

7.8. Laxatives

7.9. Others

Chapter 8.  GASTROINTESTINAL THERAPEUTICS MARKET – By Route Of Administration

8.1. Injectable

8.2. Oral

8.3. Others

Chapter 9.  GASTROINTESTINAL THERAPEUTICS MARKET – By Application

9.1. GERD

9.2. IBS

9.3. Crohn's disease

9.4. Ulcerative colitis

9.5. Others

Chapter 10.  GASTROINTESTINAL THERAPEUTICS MARKET – By Distribution Channel

10.1. Online Pharmacies

10.2. Hospital Pharmacies

10.3. Retail Pharmacies

Chapter 11.  GASTROINTESTINAL THERAPEUTICS MARKET – By Region

11.1. North America

11.2. Europe

11.3. Asia-P2acific

11.4. Latin America

11.5. The Middle East

11.6. Africa

Chapter 12.  GASTROINTESTINAL THERAPEUTICS MARKET – By Companies

12.1. Companies 1

12.2. Companies 2

12.3. Companies 3 

12.4. Companies 4

12.5. Companies 5

12.6. Companies 6

12.7. Companies 7

12.8. Companies 8

12.9. Companies 9

1210. Companies 10